Finance.Foundation
Comparison · seed-0.6 · 2026-08-29

NVIDIA (NVDA) vs Eli Lilly (LLY)

NVIDIA (NVDA) and Eli Lilly (LLY) side by side: Technology vs Healthcare, listed on Nasdaq Stock Market and New York Stock Exchange. NVIDIA is the larger of the two by approximate market capitalization (about 5.1×).

FieldNVIDIAEli Lilly
Legal nameNVIDIA CorporationEli Lilly and Company
TickerNVDALLY
ExchangeNasdaq Stock Market XNASNew York Stock Exchange XNYS
JurisdictionUnited StatesUnited States
SectorTechnologyHealthcare
IndustrySemiconductorsPharmaceuticals
Market cap ≈$3.8tn$750bn
Founded19931876
Reporting currencyUSDUSD
LEI549300S4KLFTLO7GSQ80FRDRIPF3EKNDJ2CQJL29
ISINUS67066G1040US5324571083
FIGIBBG001S5TZJ6BBG001S5STL8
Index membershipS&P 500, Nasdaq-100S&P 500
Held by (covered funds)81

NVIDIA

GPUs and accelerated-computing platforms; the dominant supplier of AI training and inference hardware.

Full profile →

Eli Lilly

Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.

Full profile →

What they share

Same indices: S&P 500
Held by the same funds: iShares Core MSCI World UCITS ETF

Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/nvidia · /api/v1/companies/eli-lilly